Results 31 to 40 of about 224,806 (322)

Fluconazole resistance in Candida glabrata [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 1993
We report a case of infection with Candida glabrata in which the organism became resistant to fluconazole and in which pre- and posttreatment isolates were available for comparison. The organism was cross-resistant to ketoconazole and itraconazole, in common with other azole-resistant yeasts.
C A, Hitchcock   +4 more
openaire   +2 more sources

Genetic Transformation of Candida glabrata by Heat Shock

open access: yesBio-Protocol, 2015
Here, we report a method for the transformation of Candida glabrata using a heat shock method. The protocol can be used for transformations in single well or in 96-well scale.
Fabian Istel   +3 more
doaj   +1 more source

Candida Glabrata Perinephric Abscess

open access: yesThe Eurasian Journal of Medicine, 2011
Perinephric abscess is a rare complication of urinary tract infections, and the etiology is usually a gram negative bacillus. We report a case of Candida glabrata perinephric abscess in a patient with diabetes mellitus who had a recent episode of pyelonephritis that was treated with antibiotics.
Geduk, Ayfer   +5 more
openaire   +5 more sources

Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study [PDF]

open access: yes, 2013
Background: Candida spp. are a frequent cause of nosocomial bloodstream infections worldwide. Objective: To evaluate the use patterns and outcomes associated with intravenous (IV) fluconazole therapy in intensive care units in Spain and Germany ...
Ballus, Jose   +7 more
core   +1 more source

An expanded toolkit of drug resistance cassettes for Candida glabrata, Candida auris, and Candida albicans leads to new insights into the ergosterol pathway

open access: yesmSphere, 2023
The World Health Organization recently published the first list of priority fungal pathogens highlighting multiple Candida species, including Candida glabrata, Candida albicans, and Candida auris.
Justin B. Gregor   +8 more
doaj   +1 more source

Bloodstream yeast infections: a 15-month survey [PDF]

open access: yes, 2009
A 15-month survey of 412 bloodstream yeast isolates from 54 Belgian hospitals was undertaken. Candida albicans was the most common species (47.3%) followed by C. glabrata (25.7%), C. parapsilosis (8.0%), C. tropicalis (6.8%) and Saccharomyces cerevisiae (
Detandt, M   +3 more
core   +1 more source

Candida glabrata infection of the amniotic fluid with chorioamnionitis and maternal candidemia and a negative 1,3-β-D-glucan test: A case report

open access: yesCase Reports in Women's Health, 2022
A case is reported of Candida glabrata microbial invasion of the amniotic cavity and maternal candidemia with a negative 1,3-β-D-glucan test. A 28-year-old singleton pregnant woman (gravida 1, para 0) presented at 18 weeks and 3 days of gestation ...
Michihisa Shiro   +3 more
doaj   +1 more source

Candida glabrata meningitis and endocarditis: a late severe complication of candidemia

open access: yesInternational Journal of Infectious Diseases, 2014
We report an unusual case of Candida glabrata meningitis and endocarditis in a young Caucasian woman with a prosthetic aortic valve and suffering from a dissecting thoraco-abdominal aortic aneurysm. C.
Claudia Colomba   +5 more
doaj   +1 more source

Surface disinfection challenges for Candida auris: an in-vitro study [PDF]

open access: yes, 2018
The emerging pathogenic multidrug-resistant yeast Candida auris is an important source of healthcare-associated infections and of growing global clinical concern.
Akinbobola, A.   +9 more
core   +4 more sources

Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure

open access: yesMycoses (Berlin), 2020
Candida glabrata is the third leading cause of candidaemia in Turkey; however, the data regarding antifungal resistance mechanisms and genotypic diversity in association with their clinical implication are limited.
A. Arastehfar   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy